As the SCOPE Summit approaches next week, it's clear sponsors and CROs still face many of the same site activation and patient enrollment challenges across…
The threat of Coronavirus (COVID-19) is real and spreading. The most vulnerable among us (the…
As the coronavirus continues to spread and dominate the media, we are inundated with advice…
There are many ways a clinical trial can go wrong: There might be delays in site identification, initiation, or…
Above image: countries with confirmed COVID-19 cases as of March 10th. Credit: CDC.gov Below image:…
We recently spoke with Joann Peters, Vice President Clinical Operations at Geneos Therapeutics, a biotech…
After record attendance and a high energy atmosphere at SCOPE 2020 in Orlando last week,…
We recently talked with Mike Keens, Chief Operating Officer at Firma Clinical Research, a clinical…
SCOPE 2020 is almost upon us! This year, ArcheMedX is helping to shape the conversation…
Wecome to another issue of our interview series Conversations in Clinical Trial Readiness, by ArcheMedX.…
Does this scenario ring a bell? Your trial is about to go live - and…
When I first wrote this blog, I anticipated that 2020 would be a year that…
We recently talked with Atlantic Research Group (ARG) executives Shay Brill, VP at ARG, and Erin Farris, Senior Director Project Management, about clinical trial operations, how they…
We recently talked with Adam Kinsey, Executive Director, Clinical Sciences and Study Management—Oncology at Merck,…
ArcheMedX is heading west January 12th-15th for the 38th Annual JP Morgan Healthcare Conference. Let's…
When sponsors and contract research organizations (CROs) make decisions about which sites to include in…
The principal investigator (PI) meeting is a well-established (and expensive) tradition in the pharmaceutical industry.…
See how the ArcheMedX Platform can transform your organization’s learning and insights